• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Expert Review on Nonsurgical Management of Parapneumonic Effusion: Advances, Controversies, and New Directions
Semin Respir Crit Care Med. 2023 Aug;44(4):468-476. doi: 10.1055/s-0043-1769095. Epub 2023 Jul 10.ABSTRACTParapneumonic effusion and empyema are rising in incidence worldwide, particularly in association with comorbidities in an aging population. Also driving this change is the widespread uptake of pneumococcal vaccines, leading to the emergence of nonvaccine-type pneumococci and other bacteria. Early treatment with systemic antibiotics is essential but should be guided by local microbial guidelines and antimicrobial resistance patterns due to significant geographical variation. Thoracic ultrasound has emerged as a leading...
Source: Respiratory Care - July 10, 2023 Category: Respiratory Medicine Authors: Deirdre B Fitzgerald Eva Polverino Grant W Waterer Source Type: research

Effectiveness of the 10-valent pneumococcal conjugate vaccine on pediatric pneumonia confirmed by ultrasound: a matched case-control study
CONCLUSIONS: PCV10 was effective at reducing sonographically-confirmed pneumonia in children aged 3-35 months of age when compared to unvaccinated children. VE increased with the threshold used for consolidation size on ultrasound in clinic and community controls alike. This study provides evidence that lung ultrasound is a useful alternative to chest X-ray for case-control studies evaluating the effectiveness of vaccines against pneumonia.PMID:35915495 | DOI:10.1186/s12931-022-02115-5
Source: Respiratory Care - August 1, 2022 Category: Respiratory Medicine Authors: William Checkley Shakir Hossen Eric D McCollum Farhan Pervaiz Catherine H Miele Miguel A Chavez Lawrence H Moulton Nicole Simmons Arunangshu D Roy Nabidul H Chowdhury Salahuddin Ahmed Nazma Begum Abdul Quaiyum Mathuram Santosham Abdullah H Baqui Source Type: research

Abstracts of Presentations at the Association of Clinical Scientists 143 < sup > rd < /sup > Meeting Louisville, KY May 11-14,2022
Conclusion: These assays are suitable for routine diagnostic. The UltraFast NextGenPCR is the fastest with average time (30mins), followed by Agilent (2 hrs) and MassArray (6hrs). Upon completion of this activity, participants should be able to examine, measure and compare results from different assays for SARS detection, evaluate and diagnose accurately, as well as being able to plan, organize and recommend a diagnostic procedure for diagnostic laboratory. Key words: SARS-CoV-2, RNA extraction, RT-PCR, limit of detection, quantification cycle, COVID-19, in vitro diagnostic tests, Agilent, Massarray, Ultrafast. [20] From t...
Source: Annals of Clinical and Laboratory Science - July 1, 2022 Category: Laboratory Medicine Source Type: research

Comorbidities, poverty and social vulnerability as risk factors for mortality in pregnant women with confirmed SARS-CoV-2 infection: analysis of 13  062 positive pregnancies including 176 maternal deaths in Mexico
CONCLUSIONS: Our study, which is the largest prospective consecutive cohort to date, has confirmed that advanced maternal age, diabetes, hypertension, obesity, very high social vulnerability, and low socioeconomic status are risk factors of COVID-19-related mortality This article is protected by copyright. All rights reserved.PMID:34672382 | DOI:10.1002/uog.24797
Source: The Ultrasound Review of Obstetrics and Gynecology - October 21, 2021 Category: Radiology Authors: J Torres-Torres R J Martinez-Portilla S Espino-Y-Sosa G Estrada-Gutierrez J M Solis-Paredes J R Villafan-Bernal V Medina-Jimenez A J Rodriguez-Morales L Rojas-Zepeda L C Poon Source Type: research

Pages: 1  2